| Literature DB >> 34505944 |
Ajay N Sharma1, Samantha Shwe1, Vignesh Ravi2, Melanie Miller2, Natasha A Mesinkovska1, Nathan W Rojek1, Scott Worswick3.
Abstract
Recurrence of DRESS syndrome is poorly characterized, and dermatologists must be prepared to predict, identify, and manage patients after treatment of the initial presentation. In this study, a primary literature search was conducted using PubMed, capturing all articles recording cases of DRESS syndrome recurrence. Forty-two articles were included for review comprising a total of 60 patients. The average age of patients was 46.3 years and time to recurrence was 123 days. Recurrent episodes presented more frequently with a higher fever and eosinophil absolute peak. Relapse was most often attributed to the introduction of a new medication (n = 18). Of the 17 cases in which outcome data were available, the survival rate of those experiencing recurrence was 71%. Viral reactivation with HHV-6 and organ involvement of the liver were frequently recorded complications. In essence, viral reactivation, severe internal organ involvement, and hematological abnormalities all portended a poorer prognosis in those experiencing DRESS syndrome recurrence. An adequate course of treatment should be maintained until clinical and laboratory parameters normalize, with a slow taper to minimize the likelihood of relapse in those most at risk.Entities:
Keywords: DRESS; Drug hypersensitivity reaction; Drug reaction with eosinophilia and systemic symptoms; Eosinophilia; Inpatient; Recurrence
Mesh:
Year: 2021 PMID: 34505944 DOI: 10.1007/s00403-021-02274-3
Source DB: PubMed Journal: Arch Dermatol Res ISSN: 0340-3696 Impact factor: 3.033